chr2-45393041-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018079.5(SRBD1):āc.2602A>Gā(p.Met868Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018079.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRBD1 | NM_018079.5 | c.2602A>G | p.Met868Val | missense_variant | 20/21 | ENST00000263736.5 | |
SRBD1 | XM_011532946.3 | c.2554A>G | p.Met852Val | missense_variant | 20/21 | ||
SRBD1 | XM_047444861.1 | c.1159A>G | p.Met387Val | missense_variant | 12/13 | ||
SRBD1 | XM_047444862.1 | c.1159A>G | p.Met387Val | missense_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRBD1 | ENST00000263736.5 | c.2602A>G | p.Met868Val | missense_variant | 20/21 | 2 | NM_018079.5 | P1 | |
SRBD1 | ENST00000490133.5 | n.1499A>G | non_coding_transcript_exon_variant | 5/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251154Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135722
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461778Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727178
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2024 | The c.2602A>G (p.M868V) alteration is located in exon 20 (coding exon 19) of the SRBD1 gene. This alteration results from a A to G substitution at nucleotide position 2602, causing the methionine (M) at amino acid position 868 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at